Literature DB >> 17135459

Neuroimaging findings in human prion disease.

R G Macfarlane1, S J Wroe, J Collinge, T A Yousry, H R Jäger.   

Abstract

Imaging occupies an important role in the investigation of dementia and neurodegenerative disease. The role of imaging in prion disease used to be one of exclusion of other conditions. Over the past decade, the non-invasive nature of MRI, the improved range of magnetic resonance sequences and the availability of clinical and neuropathological correlation have led to a more prominent position of MRI and its inclusion in the diagnostic criteria for variant Creutzfeldt-Jakob disease. As experience of imaging in human prion disease increases, patterns of change related to strain and genotype may improve the diagnostic potential of imaging in the future, may reduce the need for more invasive testing and prove useful in future therapeutic trials. This paper reviews the current knowledge of imaging appearances in human prion disease.

Entities:  

Mesh:

Year:  2006        PMID: 17135459      PMCID: PMC2117674          DOI: 10.1136/jnnp.2006.094821

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  85 in total

1.  The pulvinar sign on magnetic resonance imaging in variant Creutzfeldt-Jakob disease.

Authors:  M Zeidler; R J Sellar; D A Collie; R Knight; G Stewart; M A Macleod; J W Ironside; S Cousens; A C Colchester; D M Hadley; R G Will; A F Colchester
Journal:  Lancet       Date:  2000-04-22       Impact factor: 79.321

2.  Diagnosis of new variant Creutzfeldt-Jakob disease.

Authors:  R G Will; M Zeidler; G E Stewart; M A Macleod; J W Ironside; S N Cousens; J Mackenzie; K Estibeiro; A J Green; R S Knight
Journal:  Ann Neurol       Date:  2000-05       Impact factor: 10.422

3.  FLAIR MRI in sporadic Creutzfeldt-Jakob disease.

Authors:  A F Vrancken; C J Frijns; L M Ramos
Journal:  Neurology       Date:  2000-07-12       Impact factor: 9.910

4.  MRI and the second French case of vCJD.

Authors:  C Oppenheim; J P Brandel; J J Hauw; J P Deslys; B Fontaine
Journal:  Lancet       Date:  2000-07-15       Impact factor: 79.321

5.  Clinical findings and diagnostic tests in the MV2 subtype of sporadic CJD.

Authors:  Anna Krasnianski; Walter J Schulz-Schaeffer; Kai Kallenberg; Bettina Meissner; Donald A Collie; Sigrun Roeber; Mario Bartl; Uta Heinemann; Daniela Varges; Hans A Kretzschmar; Inga Zerr
Journal:  Brain       Date:  2006-05-23       Impact factor: 13.501

6.  Differentiation of sCJD and vCJD forms by automated analysis of basal ganglia intensity distribution in multisequence MRI of the brain--definition and evaluation of new MRI-based ratios.

Authors:  Marius George Linguraru; Nicholas Ayache; Eric Bardinet; Miguel Angel González Ballester; Damien Galanaud; Stéphane Haïk; Baptiste Faucheux; Jean-Jacques Hauw; Patrick Cozzone; Didier Dormont; Jean-Philippe Brandel
Journal:  IEEE Trans Med Imaging       Date:  2006-08       Impact factor: 10.048

7.  Iatrogenic Creutzfeldt-Jakob disease following human growth hormone therapy: case report.

Authors:  Luís Otávio Sales Ferreira Caboclo; Nancy Huang; Guilherme Alves Lepski; José Antônio Livramento; Carlos Alberto Buchpiguel; Cláudia Sellitto Porto; Ricardo Nitrini
Journal:  Arq Neuropsiquiatr       Date:  2002-06       Impact factor: 1.420

8.  Positron emission tomography with [(18)F]FDG in the diagnosis of Creutzfeldt-Jakob disease (CJD).

Authors:  Karsten Henkel; Inga Zerr; Andreas Hertel; Klaus-F Gratz; Andreas Schröter; Henriette J Tschampa; Heiner Bihl; Udalrich Büll; Frank Grünwald; Alexander Drzezga; Jörg Spitz; Sigrid Poser
Journal:  J Neurol       Date:  2002-06       Impact factor: 4.849

9.  Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report.

Authors:  Stephen J Wroe; Suvankar Pal; Durrenajaf Siddique; Harpreet Hyare; Rebecca Macfarlane; Susan Joiner; Jacqueline M Linehan; Sebastian Brandner; Jonathan D F Wadsworth; Patricia Hewitt; John Collinge
Journal:  Lancet       Date:  2006-12-09       Impact factor: 79.321

10.  Conflicting MRI signals from gliosis and neuronal vacuolation in prion diseases.

Authors:  Y L Chung; A Williams; D Ritchie; S C Williams; K K Changani; J Hope; J D Bell
Journal:  Neuroreport       Date:  1999-11-26       Impact factor: 1.837

View more
  30 in total

1.  Sporadic Creutzfeldt-Jakob disease: early signs and pre-mortem diagnosis.

Authors:  Etienne Laverse; Shahid Shah; Milica Mavra
Journal:  BMJ Case Rep       Date:  2009-12-07

Review 2.  Using NMR spectroscopy to investigate the role played by copper in prion diseases.

Authors:  Rawiah A Alsiary; Mawadda Alghrably; Abdelhamid Saoudi; Suliman Al-Ghamdi; Lukasz Jaremko; Mariusz Jaremko; Abdul-Hamid Emwas
Journal:  Neurol Sci       Date:  2020-04-24       Impact factor: 3.307

3.  Infectious disease - developments in the field of Creutzfeldt-Jakob disease.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Rev Neurol Dis       Date:  2007

Review 4.  The clinical use of structural MRI in Alzheimer disease.

Authors:  Giovanni B Frisoni; Nick C Fox; Clifford R Jack; Philip Scheltens; Paul M Thompson
Journal:  Nat Rev Neurol       Date:  2010-02       Impact factor: 42.937

Review 5.  Neuroimaging in Dementia.

Authors:  Adam M Staffaroni; Fanny M Elahi; Dana McDermott; Kacey Marton; Elissaios Karageorgiou; Simone Sacco; Matteo Paoletti; Eduardo Caverzasi; Christopher P Hess; Howard J Rosen; Michael D Geschwind
Journal:  Semin Neurol       Date:  2017-12-05       Impact factor: 3.420

6.  High-b-value diffusion MR imaging and basal nuclei apparent diffusion coefficient measurements in variant and sporadic Creutzfeldt-Jakob disease.

Authors:  H Hyare; J Thornton; J Stevens; S Mead; P Rudge; J Collinge; T A Yousry; H R Jäger
Journal:  AJNR Am J Neuroradiol       Date:  2009-12-10       Impact factor: 3.825

7.  Unusual cause of dementia in an immunocompetent host: toxoplasmic encephalitis.

Authors:  Mario Habek; David Ozretić; Kamelija Zarković; Visnja Djaković; Zdenko Mubrin
Journal:  Neurol Sci       Date:  2009-01-16       Impact factor: 3.307

8.  Progressive Stroke-Like Symptoms in a Patient with Sporadic Creutzfeldt-Jakob Disease.

Authors:  Jukka Lyytinen; Tiina Sairanen; Leena Valanne; Tapani Salmi; Anders Paetau; Eero Pekkonen
Journal:  Case Rep Neurol       Date:  2010-03-12

Review 9.  Neuroimaging biomarkers of neurodegenerative diseases and dementia.

Authors:  Shannon L Risacher; Andrew J Saykin
Journal:  Semin Neurol       Date:  2013-11-14       Impact factor: 3.420

10.  Magnetic resonance diagnostic markers in clinically sporadic prion disease: a combined brain magnetic resonance imaging and spectroscopy study.

Authors:  Raffaele Lodi; Piero Parchi; Caterina Tonon; David Manners; Sabina Capellari; Rosaria Strammiello; Rita Rinaldi; Claudia Testa; Emil Malucelli; Barbara Mostacci; Giovanni Rizzo; Giulia Pierangeli; Pietro Cortelli; Pasquale Montagna; Bruno Barbiroli
Journal:  Brain       Date:  2009-09-15       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.